| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
14,237 |
13,350 |
$4.85M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
6,676 |
6,236 |
$1.89M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
4,552 |
4,425 |
$1.73M |
| 80053 |
Comprehensive metabolic panel |
6,272 |
5,576 |
$656K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
8,393 |
2,399 |
$407K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,260 |
1,199 |
$291K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,164 |
2,032 |
$215K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
946 |
924 |
$173K |
| 70450 |
Computed tomography, head or brain; without contrast material |
684 |
672 |
$165K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
504 |
494 |
$88K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
433 |
316 |
$85K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
1,164 |
410 |
$83K |
| 97164 |
|
615 |
604 |
$72K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,925 |
1,897 |
$55K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
217 |
215 |
$54K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
2,046 |
771 |
$39K |
| 97162 |
|
231 |
231 |
$38K |
| 97010 |
|
3,225 |
1,064 |
$36K |
| 12011 |
|
104 |
103 |
$29K |
| 20610 |
|
84 |
80 |
$27K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
235 |
221 |
$26K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
377 |
377 |
$21K |
| 36415 |
Collection of venous blood by venipuncture |
1,462 |
1,422 |
$13K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
67 |
67 |
$10K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,054 |
985 |
$10K |
| 97161 |
|
111 |
111 |
$10K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
3,462 |
2,980 |
$8K |
| 90715 |
|
80 |
80 |
$7K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
156 |
74 |
$7K |
| 83880 |
|
79 |
77 |
$4K |
| 71046 |
Radiologic examination, chest; 2 views |
736 |
726 |
$4K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
15 |
14 |
$3K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
787 |
772 |
$3K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
12 |
12 |
$3K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
2,324 |
2,129 |
$2K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
345 |
345 |
$2K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,573 |
1,421 |
$2K |
| 71045 |
Radiologic examination, chest; single view |
1,161 |
1,111 |
$1K |
| 73610 |
|
176 |
173 |
$1K |
| 73630 |
|
203 |
190 |
$1K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
3,285 |
2,956 |
$1K |
| 81001 |
|
1,350 |
1,290 |
$868.75 |
| 97014 |
|
35 |
13 |
$581.40 |
| 73562 |
|
127 |
118 |
$564.01 |
| 97116 |
|
38 |
13 |
$544.75 |
| 76830 |
Ultrasound, transvaginal |
15 |
15 |
$537.30 |
| 87430 |
|
733 |
722 |
$505.74 |
| 84484 |
|
1,006 |
833 |
$465.22 |
| 87400 |
|
617 |
603 |
$418.02 |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
25 |
25 |
$380.76 |
| 73130 |
|
73 |
65 |
$330.28 |
| 93041 |
|
936 |
893 |
$305.49 |
| 86769 |
|
17 |
17 |
$294.91 |
| 83690 |
|
963 |
885 |
$261.14 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
78 |
76 |
$138.87 |
| 73030 |
|
31 |
30 |
$108.55 |
| 72100 |
|
13 |
13 |
$104.69 |
| 84703 |
|
1,345 |
1,267 |
$84.34 |
| 83735 |
|
406 |
373 |
$65.51 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
1,855 |
1,656 |
$61.26 |
| 73110 |
|
15 |
15 |
$57.51 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
914 |
859 |
$39.19 |
| 87070 |
|
191 |
182 |
$36.47 |
| 83605 |
|
13 |
12 |
$25.65 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
178 |
165 |
$24.07 |
| 81003 |
|
332 |
323 |
$24.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
715 |
666 |
$20.08 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
577 |
525 |
$19.51 |
| 87807 |
|
32 |
32 |
$10.48 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
58 |
57 |
$8.07 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
29 |
24 |
$2.37 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
308 |
296 |
$2.18 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
37 |
37 |
$0.00 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
29 |
28 |
$0.00 |
| 85730 |
|
24 |
24 |
$0.00 |
| 85610 |
|
54 |
54 |
$0.00 |